Stock FLHLF FILAMENT HEALTH CORP.
Add to a list
To use this feature you must be a member
Log inSign up

All News Filament Health Corp.

Equities

FLHLF

CA31685W1068

Delayed OTC Markets
Other stock markets
 09:57:11 2024-04-19 am EDT 		5-day change 1st Jan Change
0.032 USD -14.21% Intraday chart for Filament Health Corp. -14.21% -40.85%
Apr. 03 Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 28 Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET
AQ
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
AQ
Filament Health Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS
AQ
Filament Health Corp. Announces Appointment of Michael Messinger to Its Board of Directors and Chair of the Audit Committee
CI
Filament Health Corp. Announces Chief Financial Officer Changes
CI
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION
AQ
Filament Health Corp. Announces Shipments of Botanical Psilocybin to Four Countries for Clinical Investigation
CI
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL
AQ
Filament Health Corp. Completes the First Export of Botanical Psilocybin to Israel
CI
FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS
AQ
Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders
CI
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions
AQ
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA
AQ
Filament Health Completes the First Export of Biological Psilocybin to Australia
CI
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS
AQ
Filament Health Announces Change to Board of Directors
CI
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION
AQ
FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE
AQ
Filament Health Corp. (OTCPK:FLHL.F) cancelled the acquisition of Jupiter Acquisition Corporation from a group of shareholders in a reverse merger transaction.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FLHLF Stock
  4. News Filament Health Corp.